Internal Medicine, Hematology & Oncology · Omaha, NE
NPI
1598717845
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
988102 Nebraska Medical Ctr
Omaha, NE, 68198
Phone (402) 559-5600
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,059 services
Medicare patients, 2024
331
Average age 72
Drug cost, 2024
$3.4M
827 prescriptions
Company payments, 2025
$7,882
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julie M Vose was code 99233 (hospital e&m - subsequent), 266 times for 65 patients. In total Julie M Vose billed 1,059 services in 14 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 266 | 65 | $86.31 | $23K |
| 99215 Office E&M - Established | Facility | 193 | 70 | $101.05 | $20K |
| 99214 Office E&M - Established | Facility | 125 | 84 | $65.59 | $8,199 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 81 | 44 | $11.95 | $968 |
| 99215 Office E&M - Established | Office | 80 | 31 | $99.80 | $7,984 |
| 99214 Office E&M - Established | Office | 75 | 61 | $59.30 | $4,448 |
| 99223 Hospital E&M - Initial | Facility | 45 | 37 | $126.15 | $5,677 |
| 99213 Office E&M - Established | Office | 38 | 36 | $37.93 | $1,441 |
| 99213 Office E&M - Established | Facility | 36 | 34 | $33.91 | $1,221 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 35 | 26 | $11.41 | $399 |
| 99239 Hospital Discharge Management | Facility | 33 | 29 | $83.25 | $2,747 |
| 99205 Office E&M - New | Facility | 30 | 30 | $120.76 | $3,623 |
| 99205 Office E&M - New | Office | 11 | 11 | $128.64 | $1,415 |
By year: 2022 $68K for 815 services; 2023 $78K for 937 services; 2024 $81K for 1,059 services.
Medicare prescription drug claims, 2024
In 2024, the drug Julie M Vose prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 84 prescriptions and refills. In total Julie M Vose wrote 827 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 84 | 159 | 33 | $570 |
| Prednisone Generic | 84 | 86 | 27 | $246 |
| Acyclovir Generic | 83 | 154 | 31 | $1,543 |
| Brukinsa Zanubrutinib | 80 | 82 | Under 11 | $979K |
| Imbruvica Ibrutinib | 52 | 52 | Under 11 | $786K |
| Venclexta Venetoclax | 51 | 51 | Under 11 | $689K |
| Calquence Acalabrutinib Maleate | 34 | 34 | Under 11 | $440K |
| Allopurinol Generic | 33 | 37 | 26 | $91.97 |
| Ondansetron Odt Ondansetron | 24 | 24 | 12 | $330 |
| Eliquis Apixaban | 24 | 26 | Under 11 | $14K |
| Ondansetron Hcl Generic | 22 | 22 | 18 | $120 |
| Metoclopramide Hcl Generic | 20 | 20 | 13 | $47.69 |
| Pedvaxhib Haemph B Polysac Conj-Menin/Pf | 18 | 18 | Under 11 | $531 |
| Gabapentin Generic | 17 | 30 | Under 11 | $303 |
| Levothyroxine Sodium Generic | 15 | 39 | Under 11 | $194 |
Brand drugs: - claims; generic drugs: 471 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie M Vose $7,882 ($6,596 in general payments such as food, travel and fees and $1,286 for research) from 11 companies. The largest payer was Genentech USA, Inc. with $3,485.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.